Paclitaxel and Capecitabine in Patients With Metastatic/Recurrence Esophageal Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00453323
Recruitment Status : Unknown
Verified July 2010 by National Cancer Center, Korea.
Recruitment status was:  Active, not recruiting
First Posted : March 28, 2007
Last Update Posted : July 12, 2010
Information provided by:
National Cancer Center, Korea

No Study Results Posted on for this Study
  Recruitment Status : Unknown
  Primary Completion Date : December 2009
  Estimated Study Completion Date : December 2010